A Dose of Reality with Charles Spence9 Sep 2024

Re-Entering the Workforce and Career Growth in Regulatory Affairs with Mary Christian

How do you balance a career in regulatory affairs with family life? In this episode, Charles discusses this topic with Mary Christian, the Senior Vice President of Regulatory and Safety at C4 Therapeutics, a biopharmaceutical company focused on targeted protein degradation. They talk about the importance of effective communication, career development, and work-life balance in the pharmaceutical industry.

Mary also offers advice for young mothers and career professionals on making choices that align with their personal and professional goals, highlighting the evolving nature of career and family life.

Here's what you're in:

00:02 Introduction and Career Background

07:52 Building Capabilities for Career Reentry

16:42 C4 Therapeutics and Protein Degradation

24:00 Communication in Clinical Trials

28:35 Overcoming Challenges in Decision-Making

35:47 Shifting Perspectives in Career Growth

42:01 Balancing Career and Family Life

About Mary Christian

Mary Christian, PharmD, MBA, is the Senior Vice President of Regulatory and Safety at C4 Therapeutics, Inc. A passionate and decisive biopharma executive, leader, and advisor, Mary delivers visionary solutions across all phases of drug development. She has demonstrated success in creating, building, and integrating novel capabilities in an international biopharma environment, as well as deconstructing organizations to create fit-for-purpose solutions and value opportunities.

Apart from her work, Mary is devoted to mentoring through initiatives like Project Onramp. She has also steered many company changes. On top of her career, she's a proud mom to three accomplished adults and a loving grandmother to four girls.

Connect with Mary:

LinkedIn: https://www.linkedin.com/in/mary-christianpharmd

Website: https://c4therapeutics.com/

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry. He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn:https://www.linkedin.com/in/charles-spence-clinical/

Website: https://www.discera-search.com/

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(74)

Eliot Forster, CEO at Levicept on 30 Years in Pharma, Running a Six-Person Biotech, and the Future of European Drug Development

In this episode, I talked with Eliot Forster, CEO of Levicept, a neurophysiologist-turned biotech veteran with 30+ years of experience across Big Pharma and a series of CEO roles. We get into clinical...

7 Sep 45min

Michael Zaiac, Medical Affairs Lead for Oncology at Daiichi Sankyo on 30 Years of Hiring Lessons, The ADC Wave, and Building Teams in a Fast-Moving Pipeline

In this episode, I talked with Michael Zaiac, Medical Affairs Lead for Oncology across Europe and Canada at Daiichi Sankyo — a trained surgical oncologist who walked away from the operating table, mov...

24 Aug 39min

Juho Jalkanen, CEO at Faron Pharmaceuticals on From Surgeon to CEO, Rethinking Boards, and Fighting for the Right Science

In this episode, I talked with Dr. Juho Jalkanen, CEO of Faron Pharmaceuticals — a publicly listed Finnish biotech building novel immunotherapies for blood cancers. Juho's path is unlike most you'll h...

10 Aug 37min

Tobias Kampfenkel, MD, MHBA, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine, on Transformative Drugs in Oncology and Autoimmunity: It's Always the Team!

In this episode, I talked with Dr. Tobias Kampfenkel, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine. Tobias spent nearly a decade at Janssen building ...

15 Jun 39min

Sofia Heigis, CEO of OncoPeptides, From Sales Rep to CEO, Being "Present", and Hiring for Self-Insight

In this episode, I talked with Sofia Heigis, Chief Executive Officer of OncoPeptides, about a career path that did not start where she expected. Sofia originally wanted to move into clinical operation...

31 Mai 38min

Jens Lindberg, CEO at Medivir, on The Biotech Rollercoaster - Medivir´s Previous Four Months (and Biotech Today in 2026)

In this episode, I talked with Jens Lindberg, CEO of Medivir AB, a Swedish biotech developing innovative therapies in liver cancer and rare disease. Jens brings over 30 years of late-stage development...

18 Mai 33min

Hubert Truebel, Managing Director at DEBRA Research, on Creating Own Career Opportunities...and a Practical Approach to Longevity

In this episode, I talked with Hubert Truebel, Managing Director at DEBRA Research, to discover a career that wasn’t built traditionally—but through creating opportunities where none formally existed....

4 Mai 28min

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like ...

30 Mar 42min